New insights into liver cancer using organoids

by Princess Máxima Center for Pediatric OncologyA culture of mini livers. Credit: Benedetta Artegiani / Princess Máxima Center for pediatric oncologyScientists of the Princess Máxima Center for pediat

Updated on: February 24,2024

New insights into liver cancer using organoids

by Princess Máxima Center for Pediatric OncologyA culture of mini livers. Credit: Benedetta Artegiani / Princess Máxima Center for pediatric oncologyScientists of the Princess Máxima Center for pediat

Updated on:February 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on: March 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on:March 24,2024

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n

Updated on: January 08,2024

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n

Updated on:January 08,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on: August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on:August 28,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on: February 24,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on:February 24,2024

Vaginal cancer incidence increasing globally

by Lori SolomonThe incidence of vaginal cancer is increasing globally, according to a studypublishedonline June 25 inBJOG: An International Journal of Obstetrics and Gynaecology.Junj

Updated on: July 05,2024

Vaginal cancer incidence increasing globally

by Lori SolomonThe incidence of vaginal cancer is increasing globally, according to a studypublishedonline June 25 inBJOG: An International Journal of Obstetrics and Gynaecology.Junj

Updated on:July 05,2024

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on: September 30,2024

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on:September 30,2024

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n

Updated on: February 20,2024

Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells

by Queen Mary, University of LondonInhibition of FGFR1 limits invasion in pre-clinical models of PDAC.ARepresentative H&E images of MIA PaCa-2: PS1 organotypics treated with 100 n

Updated on:February 20,2024

Zika virus vaccine emerges as an unlikely hero in battling brain cancer

by Duke-NUS Medical SchoolCultured human neurons infected with ZIKV-LAV. Infection in pink and cell nuclei in blue. Credit: Duke-NUS Medical SchoolScientists from Duke-NUS Medical School (Duke-NU

Updated on: March 20,2024

Zika virus vaccine emerges as an unlikely hero in battling brain cancer

by Duke-NUS Medical SchoolCultured human neurons infected with ZIKV-LAV. Infection in pink and cell nuclei in blue. Credit: Duke-NUS Medical SchoolScientists from Duke-NUS Medical School (Duke-NU

Updated on:March 20,2024

Why do cancer patients lose weight? Study points to elevated lactate levels

byNature Publishing GroupSchematic illustration depicting the signaling cascade downstream of lactate/GPR81 in promoting cancer cachexia. Credit:Nature Metabolism(2024). DOI: 10.1038

Updated on: March 30,2024

Why do cancer patients lose weight? Study points to elevated lactate levels

byNature Publishing GroupSchematic illustration depicting the signaling cascade downstream of lactate/GPR81 in promoting cancer cachexia. Credit:Nature Metabolism(2024). DOI: 10.1038

Updated on:March 30,2024

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on: December 28,2023

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on:December 28,2023

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on: March 30,2024

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Updated on:March 30,2024